We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · January 24, 2022

Predicting Patients' Responses to Methotrexate Using Machine Learning

Arthritis Care & Research


Additional Info

Arthritis Care & Research
Towards Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: a Pharmacogenomics-driven Machine Learning Approach
Arthritis Care Res (Hoboken) 2021 Dec 13;[EPub Ahead of Print], E Myasoedova, AP Athreya, CS Crowson, JM Davis, KJ Warrington, RC Walchak, E Carlson, KR Kalari, T Bongartz, PP Tak, RF van Vollenhoven, L Padyukov, P Emery, A Morgan, L Wang, RM Weinshilboum, EL Matteson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading